Common Contracts
3 similar Securities Purchase Agreement contracts by Cardiff Oncology, Inc., Aridis Pharmaceuticals, Inc.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 12th, 2022 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Securities Purchase Agreement (this “Agreement”) is entered into as of December __, 2022 (the “Effective Date”), by and between Aridis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchaser identified on the signature pages hereto (the “Subscriber”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 19th, 2020 • Cardiff Oncology, Inc. • Biological products, (no disgnostic substances) • California
This Securities Purchase Agreement (this “Agreement”) is entered into as of May 14, 2020 (the “Effective Date”), by and between Cardiff Oncology, Inc., a Delaware corporation (the “Company”), and the subscriber identified on the signature pages hereto (the “Subscriber”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 13th, 2020 • Cardiff Oncology, Inc. • Biological products, (no disgnostic substances) • California
This Securities Purchase Agreement (this “Agreement”) is entered into as of May 11, 2020 (the “Effective Date”), by and between Cardiff Oncology, Inc., a Delaware corporation (the “Company”), and the subscriber identified on the signature pages hereto (the “Subscriber”).
